Using well known biomarkers (CA24-2, CA19-9, CA72-4, and CEA) of CRC as benchmarks, serum CDH3 demonstrated superior performance than CA24-2, CA19-9, and CEA for distant metastatic CRCs. The gene discussed is CDH3; the disease is colorectal carcinoma.